Búsqueda | Portal de Búsqueda de la BVS España

1.

Regulation of Molecular Diagnostics.

Javitt, Gail H; Vollebregt, Erik R.

Annu Rev Genomics Hum Genet; 23: 653-673, 2022 08 31.

Artículo en Inglés | MEDLINE | ID: mdl-36044907

2.

Who's on third? Regulation of third-party genetic interpretation services.

Guerrini, Christi J; Wagner, Jennifer K; Nelson, Sarah C; Javitt, Gail H; McGuire, Amy L.

Genet Med; 22(1): 4-11, 2020 01.

Artículo en Inglés | MEDLINE | ID: mdl-31402353

3.

Regulatory Landscape for Clinical Decision Support Technology.

Javitt, Gail H.

Anesthesiology; 128(2): 247-249, 2018 02.

Artículo en Inglés | MEDLINE | ID: mdl-29337741

4.

Policy implications of genetic testing: not just for geneticists anymore.

Javitt, Gail H.

Adv Chronic Kidney Dis; 13(2): 178-82, 2006 Apr.

Artículo en Inglés | MEDLINE | ID: mdl-16580620

5.

Oversight of US genetic testing laboratories.

Hudson, Kathy L; Murphy, Juli A; Kaufman, David J; Javitt, Gail H; Katsanis, Sara H; Scott, Joan.

Nat Biotechnol; 24(9): 1083-90, 2006 Sep.

Artículo en Inglés | MEDLINE | ID: mdl-16964214

6.

Regulation of next generation sequencing.

Javitt, Gail H; Carner, Katherine Strong.

J Law Med Ethics; 42 Suppl 1: 9-21, 2014.

Artículo en Inglés | MEDLINE | ID: mdl-25298288

7.

Take another little piece of my heart: regulating the research use of human biospecimens.

Javitt, Gail H.

J Law Med Ethics; 41(2): 424-39, 2013.

Artículo en Inglés | MEDLINE | ID: mdl-23802895

8.

In search of a coherent framework: options for FDA oversight of genetic tests.

Javitt, Gail H.

Food Drug Law J; 62(4): 617-52, 2007.

Artículo en Inglés | MEDLINE | ID: mdl-18557224

9.

Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats.

Javitt, Gail H.

J Health Care Law Policy; 8(1): 38-70, 2005.

Artículo en Inglés | MEDLINE | ID: mdl-16538801

10.

Drugs and vaccines for the common defense: refining FDA regulation to promote the availability of products to counter biological attacks.

Javitt, Gail H.

J Contemp Health Law Policy; 19(1): 37-116, 2002.

Artículo en Inglés | MEDLINE | ID: mdl-12733223

11.

Reproductive genetics 1991-2002: a selected annotated legal bibliography of genetic testing, gene transfer and reproductive cloning.

Javitt, Gail H.

J Health Care Law Policy; 6(2): 317-80, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-15017957

12.

Pink or blue? The need for regulation is black and white.

Javitt, Gail H.

Fertil Steril; 86(1): 13-5, 2006 Jul.

Artículo en Inglés | MEDLINE | ID: mdl-16818030

13.

Regulating (for the benefit of) future persons: a different perspective on the FDA's jurisdiction to regulate human reproductive cloning.

Javitt, Gail H; Hudson, Kathy.

Utah Law Rev; 2003(4): 1201-29, 2003.

Artículo en Inglés | MEDLINE | ID: mdl-15622618

14.

Tobacco advertising in the United States: a proposal for a constitutionally acceptable form of regulation.

Bayer, Ronald; Gostin, Lawrence O; Javitt, Gail H; Brandt, Allan.

JAMA; 287(22): 2990-5, 2002 Jun 12.

Artículo en Inglés | MEDLINE | ID: mdl-12052129

15.

The right prescription for personalized genetic medicine.

Javitt, Gail H; Hudson, Kathy.

Per Med; 4(2): 115-118, 2007 May.

Artículo en Inglés | MEDLINE | ID: mdl-29788624

16.

Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.

Javitt, Gail H; Stanley, Erica; Hudson, Kathy.

Oklahoma Law Rev; 57(2): 251-302, 2004.

Artículo en Inglés | MEDLINE | ID: mdl-15658034

Portal de Búsqueda de la BVS España

Información y Conocimiento para la Salud

Configurar filtros

Su selección (0)

Formato de exportación:

Exportar:

Regulation of Molecular Diagnostics.

Who's on third? Regulation of third-party genetic interpretation services.

Regulatory Landscape for Clinical Decision Support Technology.

Policy implications of genetic testing: not just for geneticists anymore.

Oversight of US genetic testing laboratories.

Regulation of next generation sequencing.

Take another little piece of my heart: regulating the research use of human biospecimens.

In search of a coherent framework: options for FDA oversight of genetic tests.

Old legacies and new paradigms: confusing "research" and "treatment" and its consequences in responding to emergent health threats.

Drugs and vaccines for the common defense: refining FDA regulation to promote the availability of products to counter biological attacks.

Reproductive genetics 1991-2002: a selected annotated legal bibliography of genetic testing, gene transfer and reproductive cloning.

Pink or blue? The need for regulation is black and white.

Regulating (for the benefit of) future persons: a different perspective on the FDA's jurisdiction to regulate human reproductive cloning.

Tobacco advertising in the United States: a proposal for a constitutionally acceptable form of regulation.

The right prescription for personalized genetic medicine.

Direct-to-consumer genetic tests, government oversight, and the First Amendment: what the government can (and can't) do to protect the public's health.